Sale!

CYP7B1 Gene SPG5A Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CYP7B1 gene SPG5A genetic test is a specialized diagnostic tool designed to identify mutations in the CYP7B1 gene, which are linked to Spastic Paraplegia 5A (SPG5A). SPG5A is a form of hereditary spastic paraplegia, a group of genetic disorders characterized by progressive weakness and spasticity of the legs. Mutations in the CYP7B1 gene disrupt the normal function of enzymes involved in cholesterol metabolism, leading to the symptoms associated with SPG5A.

This genetic test involves analyzing the patient’s DNA to detect specific mutations in the CYP7B1 gene that are known to cause SPG5A. It is a crucial step in the diagnosis of SPG5A, allowing for a precise genetic diagnosis that can inform treatment strategies, provide information on the course of the disease, and offer insight into the risk of passing the condition on to future generations.

The test is available at DNA Labs UAE, a leading facility for genetic testing in the United Arab Emirates. The cost of the CYP7B1 gene SPG5A genetic test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive analysis involved in identifying the genetic mutations associated with SPG5A, utilizing advanced genomic technologies to ensure accurate and reliable results. Patients considering this test should consult with a healthcare professional or genetic counselor to understand the implications of the test results and to receive personalized advice based on their specific situation.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CYP7B1 Gene SPG5A Genetic Test

Test Details

The CYP7B1 gene is associated with a condition called SPG5A, which stands for spastic paraplegia type 5A. SPG5A is a rare neurodegenerative disorder characterized by progressive stiffness and weakness of the legs (spastic paraplegia).

An NGS (next-generation sequencing) genetic test is a type of genetic testing that uses advanced sequencing technology to analyze multiple genes simultaneously. In the context of SPG5A, an NGS genetic test can identify mutations or variations in the CYP7B1 gene that may be causing the condition. By identifying these genetic changes, NGS testing can help confirm a diagnosis of SPG5A and provide information about the specific genetic variant involved. This information can be useful for genetic counseling, family planning, and potentially guiding treatment options in the future.

It’s important to note that genetic testing should be ordered and interpreted by a qualified healthcare professional, such as a geneticist or genetic counselor, who can provide appropriate guidance and support.

Test Name

CYP7B1 Gene SPG5A Genetic Test

Components

Price: 4400.0 AED

Sample Condition

Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery

3 to 4 Weeks

Method

NGS Technology

Test Type

Neurological Disorders

Doctor

Neurologist

Test Department

Genetics

Pre Test Information

Clinical History of Patient who is going for CYP7B1 Gene SPG5A NGS Genetic DNA Test

A Genetic Counselling session to draw a pedigree chart of family members affected with CYP7B1 Gene SPG5A

© 2021 DNA Labs UAE. All rights reserved.

Test Name CYP7B1 Gene SPG5A Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CYP7B1 Gene SPG5A NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CYP7B1 Gene SPG5A
Test Details

The CYP7B1 gene is associated with a condition called SPG5A, which stands for spastic paraplegia type 5A. SPG5A is a rare neurodegenerative disorder characterized by progressive stiffness and weakness of the legs (spastic paraplegia).

An NGS (next-generation sequencing) genetic test is a type of genetic testing that uses advanced sequencing technology to analyze multiple genes simultaneously. In the context of SPG5A, an NGS genetic test can identify mutations or variations in the CYP7B1 gene that may be causing the condition.

By identifying these genetic changes, NGS testing can help confirm a diagnosis of SPG5A and provide information about the specific genetic variant involved. This information can be useful for genetic counseling, family planning, and potentially guiding treatment options in the future.

It’s important to note that genetic testing should be ordered and interpreted by a qualified healthcare professional, such as a geneticist or genetic counselor, who can provide appropriate guidance and support.